NEFL and supranuclear palsy, progressive, 1: Notably, the combined analysis of CSF α-synuclein, AD-related biomarkers, and NfL demonstrates high to very high diagnostic accuracy in differentiating PSP and CBS from PD, AD, MSA, and FTD [117,118].